Prospective Evaluation of Hepatocellular Carcinoma Surveillance in At-Risk Patients (Screening HCC)
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Clinical Trials Related to Hepatocellular Carcinoma
Related studies linked through entity extraction aliases.
68Ga-SorB PET/CT Imaging in Patients With Solid Tumors
- Status
- RECRUITING
- Phase
- NA
Analysis of Breath Volatile Organic Compounds Using Mass Spectrometry
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Preoperative 3D Magnetic Resonance Elastography for Predicting Surgical Risk in Patients Undergoing Hepatectomy
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
A Study of TACE in Combination With SHR-8068, Adebrelimab, and Bevacizumab Versus TACE in Participants With Incurable Hepatocellular Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Patients With Hepatocellular Carcinoma (HCC)
- Status
- NOT_YET_RECRUITING
- Phase
- NA
AI-Driven Tumor Response Evaluation for Solid Tumors
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Effects of EPA Supplementation on Patients With Unresectable Hepatocellular Carcinoma.
- Status
- COMPLETED
- Phase
- NA
AI Multimodal Model for Liver Cancer Diagnosis and Prognosis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Yttrium-90 Carbon Microsphere Radioembolization in Previously Treated Hepatocellular Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
CHARM Hepatocellular Carcinoma MEA Study
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
68Ga-FAPI-PSMA PET Imaging for the Diagnosis of Solid Tumors
- Status
- NOT_YET_RECRUITING
- Phase
- NA
GLP-1 RA Plus SOC Treatment in First-line, Metastatic Pancreatic, Colorectal, or Hepatocellular Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- EARLY_PHASE1
A First-in-Human Study of HH160 in Participants With Advanced or Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Scheduled Meditation for Improving Postoperative Outcomes in Patients Undergoing Pancreatectomy
- Status
- NOT_YET_RECRUITING
- Phase
- NA
MONTEROSA - Italian Multicenter Observational Study to Evaluate Time to Clinical Hepatic Decompensation, Quality of Life, Effectiveness, and Safety of Tremelimumab Plus Durvalumab in Patients With Advanced or Unresectable Hepatocellular Carcinoma Who Have Received no Prior Systemic Treatment.
- Status
- RECRUITING
- Phase
- N/A
HAIC vs. TACE Combined With Sintilimab and Bevacizumab for Intermediate HCC (Beyond Up-To-Seven)
- Status
- RECRUITING
- Phase
- PHASE3
AI-Based Multimodal Integration for Tumor Microenvironment Analysis and Response Prediction in HCC Treated With TACE Plus Immunotherapy and Targeted Therapy (CHANCE2601)
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
YMN-A02 for Advanced Primary Hepatocellular Carcinoma.
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Phase Ia/Ib Study of FXB0871 Monotherapy in Locally Advanced/Metastatic Solid Tumors
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1